ABSTRACT Macroautophagy/autophagy is a critical process for maintaining cellular homeostasis and has emerging implications in cancer biology. DRAM2 (DNA damage regulated autophagy modulator 2), a transmembrane protein enriched at lysosomal membranes, has been implicated in autophagy regulation; however, the upstream mechanisms governing its trafficking and function remain unclear. In this study, we identified RPS6KA3/RSK2, a stress-responsive kinase downstream of the MAPK pathway, as a novel upstream kinase of DRAM2. RPS6KA3/RSK2 interacted with and phosphorylated DRAM2 at Ser263 within its cytosolic tail. This phosphorylation was required for AP3D1/AP-3-dependent trafficking of DRAM2 to the late endosomal-lysosomal pathway, thereby facilitating autolysosome formation and sustaining autophagic flux. In contrast, the non-phosphorylatable DRAM2S263A mutant failed to bind AP3D1/AP-3, exhibited defective lysosomal trafficking, and was partially redistributed toward plasma membrane-proximal compartments, where it enhanced exosome secretion. Bioinformatic analyses revealed a strong positive correlation between RPS6KA3/RSK2 and DRAM2 expression in melanoma tissues, and elevated DRAM2 expression was associated with poor patient prognosis. Depletion of RPS6KA3/RSK2 or DRAM2 impaired autophagic flux and inhibited melanoma cell proliferation. Similarly, expression of the DRAM2S263A mutant suppressed melanoma progression in vitro and in vivo by disrupting autophagy. Moreover, DRAM2 protein levels were elevated in skin cancer tissues compared to normal tissues. Collectively, our findings uncover a phosphorylation-dependent trafficking switch that bifurcates DRAM2 function between autophagy and exosome secretion, and establish the RPS6KA3/RSK2-DRAM2 axis as a critical regulator of melanoma progression. This signaling pathway may represent a promising therapeutic target for autophagy-associated malignancies. Abbreviations: AGC: protein kinase A, G, and C families; AP-3: adaptor protein 3; CD: cytosolic domain; CSNK2/CK2: casein kinase 2; co-IP: co-immunoprecipitation; CQ: chloroquine; CREB: cAMP responsive element binding protein; CTKD: C-terminal kinase domain; DRAM2: DNA damage regulated autophagy modulator 2; EBSS: Earle’s balanced salt solution; ESCRT: endosomal sorting complexes required for transport; GEPIA: gene expression profiling interactive analysis; GPS: global positioning system; GRK7: G protein-coupled receptor kinase 7; GSK3B: glycogen synthase kinase 3 beta; IP-MS: immunoprecipitation-mass spectrometry; LAMP1: lysosome associated membrane protein 1; LAMP2: lysosome associated membrane protein 2; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MAPK: mitogen-activated protein kinase; MVB: multivesicular body; NTA: nanoparticle tracking analysis; NTKD: N-terminal kinase domain; PI4K2: phosphatidylinositol 4-kinase type 2 alpha; PRKAA2: protein kinase AMP-activated catalytic subunit alpha 2; RPS6KA3/RSK2: ribosomal protein S6 kinase A3; SKCM: skin cutaneous melanoma; SQSTM1: sequestosome 1

A metasurface absorber has been extensively utilized for the detection of various cancers in the terahertz (THz) range. This work proposes a unique octagonal structure for skin cancer detection with a graphene resonator printed on a SiO2 dielectric substrate backed by a gold (Au) ground plane. This configuration allows complete reduction of the transmitted field along with near unity absorption in an ultra-narrow frequency range. Numerical simulations demonstrate a near-perfect absorption at 2.342 THz with absorption above 90% ranging from 2.341 to 2.343THz. The narrow bandwidth is due to the strong electromagnetic (EM) confinement that leads to the localization of strong resonance in the metasurface. The underlying absorption mechanism is thoroughly examined using normalized impedance matching analysis, current distribution, electric field enhancement, and equivalent circuit model (ECM). Furthermore, the sensing capability of the proposed structure is carefully analyzed by adding analytes of various refractive indices mimicking healthy skin and skin cancer tissues. Significant resonance frequency variation is observed for cancerous analytes over healthy tissue, allowing a clear distinction between the two. The key performance parameters, including sensitivity, quality factor (Q-factor), and figure of merit (FOM), are statistically evaluated, suggesting improved sensing capabilities due to the ultra-narrowband resonance. Owing to its compact profile and polarization insensitivity characteristics, the proposed metasurface absorber presents a promising platform for early-stage skin cancer diagnosis in THz biosensing applications.

This study presents an incremental learning framework to enhance the generalization and robustness of transformer-based deep learning models for segmenting skin cancer and related tissue structures. While deep learning models often perform well on data distributions similar to their training sets, their accuracy typically degrades when exposed to novel scenarios–limiting their clinical utility in skin cancer diagnosis. To address this, we propose a biologically inspired incremental learning strategy tailored for skin cancer classification and segmentation, allowing the model to incorporate new data progressively while reducing catastrophic forgetting. Our approach integrates multiple loss functions to preserve existing knowledge while adapting to additional magnification levels. Experimental results on the in-distribution test set demonstrate consistent performance improvements: achieving 89.05% accuracy with 10$$\times$$ magnification, 92.68% with 10$$\times$$ and 5$$\times$$ combined, and 95.53% when incorporating 10$$\times$$, 5$$\times$$, and 2$$\times$$ magnifications. These findings highlight the potential of our method to improve the adaptability and reliability of deep learning systems for empirical generalization in skin cancer classification tasks.

Background: CASC15, LINC00346 and LIN00319 LncRNAs have functional roles in cutaneous biology as in the progress of skin tumors by affecting important signaling pathways involved in tumor development and progression. Objectives: To investigate the expression levels of long-noncoding RNAs CASC15, LINC00346 and LIN00319 in non-melanotic skin cancer (NMSC). Subjects and methods: This study included thirty patients with histopathological evidence of NMSC (basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (CSCC)) subdivided into two groups (I and II): Group I: Included 30 skin cancer tissue samples from non-melanotic skin cancer and subdivided into two subgroups: Ia: 15 skin cancer tissue samples from cases with BCC. Ib: Included 15 skin cancer tissue samples from patients with CSCC. Group II: Included 30 healthy skin marginal tissue samples from group 1 patients as controls and subdivided into two subgroups, IIa: Included 15 marginal tissue samples of healthy skin from group Ia patients. IIb: Included 15 marginal tissue samples of healthy skin from group Ib patients. Expression levels of LncRNAs CASC15, LINC00346 and LINC00319 were measured in cancerous and healthy skin samples through quantitative reverse transcription-PCR. Results: Statistically significant rise in the expression levels of CASC15, LINC00346 and LINC00319 LncRNAs in cancerous skin tissue of NMSC patients compared to their controls. Conclusion: In NMSC skin tissue samples, CASC15, LINC00346 and LINC00319 LncRNAs are upregulated; these findings suggested that knocking down these LncRNAs could inhibit tumour growth and migration.

Transdermal hyaluronate/cationic solid lipid nanoparticle/siRNA complex for the treatment of skin cancer.

Skin cancer (SC) contributes to 40% of global tumor incidences. Brucine (BRU) is an anticancer alkaloid that is reported to have chemopreventive activities on the SC model. Hence, this study hypothesizes to explore the potential molecular mechanism of BRU on 7,12-dimethylbenz (a)anthracene/12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA/TPA)-stimulated skin carcinogenesis via apoptotic signalling pathway. ICR male mice were separated into 4 groups: Normal control (NC); SC model (DMBA/TPA); DMBA/TPA + BRU (25mg/kg bw); and DMBA/TPA + BRU (50mg/kg bw). We assessed the change in body weight, thymus index, morphology changes in skin, liver, and renal tissue histopathology analysis, inflammatory and apoptotic markers by ELISA method, apoptotic, autophagy, and cell proliferation markers by RT-PCR methods. Current findings showed that BRU (25 and 50mg/kg bw) + DMBA/TPA-stimulated mice increased body weight and suppressed inflammation in a dose-dependent manner. BRU-administered SC model, tissue, and blood sample pro-inflammatory markers IL-4, IL-18, and IL-1β decreased, but anti-inflammatory marker IL-10 increased. Furthermore, BRU treatment normalized the apoptotic mRNA expressions Bad, Bax, Bcl-xl, and Bcl-2 expression in tissue and blood samples in a dose-dependent manner. BRU altered the histopathological changes from hepatic, skin, and renal damage. Furthermore, BRU treatment elevated the autophagy-correlated mRNA expressions, including Microtubule-associated protein 1 light chain 3-LC3, LC3-II, and Beclin1, while reducing LC3-I and p62 levels. BRU induces apoptosis, inhibits cell proliferation and maintains tissue damage. We recommended that BRU potent chemotherapeutic drug for the recovery of Skin cancer. in the future, protein levels identification needs to be studied at the next levels of animal or experimental models.

Cancer, as one of the most notorious health diseases, represents the main reason attributed to millions of worldwide deaths each year. Timely detection and accurate diagnosis are thus vital to cancer prevention and timely therapy. Traditional cancer prescreening is not only cumbersome but also heavily reliant on sufficient expert knowledge, which inevitably increases the complexity of cancer diagnosis and limits early cancer diagnosis. To overcome this problem, recent terahertz (THz) technology, as an unconventional bio-friendly detection approach, has emerged with great potential in human disease diagnosis due to its non-ionic and high-resolution features. By combining the THz detection technique and artificial intelligence technique, here we propose a dense and efficient channel attention network (DECANet) framework-based THz diagnosis system for cancer prescreening. The cancer identification and diagnosis process are transformed into one end-to-end classification process of THz signals reflected from cancer tissue. The biosamples of breast and skin cancer tissue are characterized to validate the effectiveness and applicability of the proposed approach. Our quantified results indicate that our proposed THz diagnosis framework has promising feature extraction capability for abnormal cancerous tissue and provides an effective complement tool to assist the healthcare cancer diagnosis.

Using Raman spectroscopy (RS) signals for skin cancer tissue classification has recently drawn significant attention, because of its non-invasive optical technique, which uses molecular structures and conformations within biological tissue for diagnosis. In reality, RS signals are noisy and unstable for training machine learning models. The scarcity of tissue samples also makes it challenging to learn reliable deep-learning networks for clinical usages. In this paper, we advocate a Transfer Contrasting Learning Paradigm (TCLP) to address the scarcity and noisy characteristics of the RS for skin cancer tissue classification. To overcome the challenge of limited samples, TCLP leverages transfer learning to pre-train deep learning models using RS data from similar domains (but collected from different RS equipments for other tasks). To tackle the noisy nature of the RS signals, TCLP uses contrastive learning to augment RS signals to learn reliable feature representation to represent RS signals for final classification. Experiments and comparisons, including statistical tests, demonstrate that TCLP outperforms existing deep learning baselines for RS signal-based skin cancer tissue classification.

A CPW-fed antenna sensor with high quality factor is designed to identify the skin cancer. The proposed antenna operates in the ISM band at 2.47 GHz frequency. The proposed antenna aims to exploit the variations in dielectric constants of skin, fat, and muscle tissues to enable non-invasive and early detection of skin cancer. The antenna design process involves considerations for achieving a high frequency shift and quality factor to discern subtle variations in dielectric properties. Electromagnetic simulations, utilizing advanced numerical techniques are employed to analyze the antenna's performance in different tissue environments. The proposed antenna design is optimized for enhancing its sensitivity to changes in the dielectric constants associated with healthy and cancerous skin tissues. To validate the antenna's effectiveness, experimental setups using tissue-mimicking phantoms are utilized. This research not only emphasizes the technical aspects of antenna design but also underscores the potential clinical applications for non-invasive skin cancer detection.

In this paper, a hybrid signal processing approach integrating Discrete Wavelet Transform (DWT) and classification by algorithm-based Support Vector Machine (SVM) were used to detect and classify different types of skin cancer from eleven adult patients in a variety of locations on the body.To this aim, a specific optical probe was applied to acquire diffuse light reflectance intensity from the tissue over the visible and near-infrared spectral range (400 -1000 nm).After outlier detection and removal and Kaiser-Bessel filtering as a preprocessing step on the reflectance intensity spectrum (raw data), DWT analysis with DB4 mother wavelet was used to decompose the raw signal data into 5-levels: D1-D4 and A4 coefficients, representing the optical signal sub-bands.Then, ten features were considered for evaluation, including entropy, kurtosis, skewness, mean, standard deviation, and more.These features were calculated on each DWT coefficient to find the differences in tissue states.After feature extraction and selection, 12 eigenvalues were evaluated as the input of the SVM classifier for classification of normal tissue and different cancer subtypes.Other classifiers including k-nearest neighbor, random forest, and nave bayesian were also tested and compared.Two different classification algorithms following the above steps have been developed and are describe in this work.Our studies focused on adult patients (ages: 50-90 years old) with diagnoses of malignant melanoma (MM, n=4), basal cell carcinoma (BCC, n=5) and squamous cell carcinoma (SCC, n=2).Measurements were taken first in vivo before surgery, at the site of the lesion and from healthy skin of the same patient, and ex vivo after surgical excision.The results obtained by this work show that both algorithms achieve high performance with more than 95% accuracy.Furthermore, an average area under the curve of 0.99 and a false negative rate of less than 5% are achieved.These results demonstrate the efficacy of the hybrid framework suggested here and support its potential as a suitable automated platform to distinguish between healthy and cancerous skin tissue and to differentiate between cancer types.This could support medical workers, improve the detection rate of cancerous skin lesions, and increase the efficiency of suspicious lesion assessment.

Combination of Muller matrix imaging polarimetry and artificial intelligence for classification of mice skin cancer tissue in-vitro and in-vivo

Background: Cancer is one of the leading causes of death in the world. Dharmais Cancer Hospital is set to be the National Cancer Center with an obligation to support all hospitals throughout the country that specialize in cancer. Surgical Oncology is one of the departments that handles the most cases in Dharmais Cancer Hospital. The types of cancers that are managed in Surgical Oncology Departments are breast cancer, head and neck cancer, thyroid cancer, skin cancer, and soft tissue cancer. Objective: This paper aims to find the newly diagnosed cancer patients’ characteristics and socioeconomic features in Dharmais National Cancer Center from 2017 to 2021. Methods: The study was a cross-sectional descriptive study using the medical record database of outpatients at Dharmais Cancer Hospital as a data collection method from 2017 until 2021. The sample size includes all new cancer patients in Dharmais Cancer Hospital that have been recorded. Result: Over 500,000 patients visited Dharmais Cancer Hospital in the last 5 years with an average of over 100,000 visits per year. Over 90% of the patients have solid tumors, and over eight thousand patients were admitted to the Surgical Oncology Outpatient Clinic, it was concluded that the most frequently diagnosed type of cancer is breast cancer (66.7%) of all types of cancer in the past 5 years. Most of the new patients are female (88.1%) with the most common age group of 40 to 55 years old (50.7%). Most of the patients are senior high school graduates (42.8%). Conclusions: The general characteristic of cancer patients is dominated by breast cancer patients, most patients are female, in the age group between 40 to 55 years old, and senior high school graduates. Further studies need to be done on each type of cancer to have a better understanding of the profiles and characteristics of solid cancer patients in Dharmais Cancer Hospital.

Laser hyperthermia therapy (HT) has emerged as a well-established method for treating cancer, yet it poses unique challenges in comprehending heat transfer dynamics within both healthy and cancerous tissues due to their intricate nature. This study investigates laser HT therapy as a promising avenue for addressing skin cancer. Employing two distinct near-infrared (NIR) laser beams at 980 nm, we analyze temperature variations within tumors, employing Pennes’ bioheat transfer equation as our fundamental investigative framework. Furthermore, our study delves into the influence of Ytterbium nanoparticles (YbNPs) on predicting temperature distributions in healthy and cancerous skin tissues. Our findings reveal that the application of YbNPs using a Gaussian beam shape results in a notable maximum temperature increase of 5 °C within the tumor compared to nanoparticle-free heating. Similarly, utilizing a flat top beam alongside YbNPs induces a temperature rise of 3 °C. While this research provides valuable insights into utilizing YbNPs with a Gaussian laser beam configuration for skin cancer treatment, a more thorough understanding could be attained through additional details on experimental parameters such as setup, exposure duration, and specific implications for skin cancer therapy.

Ultraviolet radiation causes skin cancer, but the exact mechanism by which it occurs and the most effective methods of intervention to prevent it are yet unknown. For this purpose, our study will use bioinformatics and systems biology approaches to discover potential biomarkers of skin cancer for early diagnosis and prevention of disease with applicable clinical treatments. This study compared gene expression and protein levels in ultraviolet-mediated cultured keratinocytes and adjacent normal skin tissue using RNA sequencing data from the National Center for Biotechnology Information-Gene Expression Omnibus (NCBI-GEO) database. Then, pathway analysis was employed with a selection of hub genes from the protein-protein interaction (PPI) network and the survival and expression profiles. Finally, potential clinical biomarkers were validated by receiver operating characteristic (ROC) curve analysis. We identified 32 shared differentially expressed genes (DEGs) by analyzing three different subsets of the GSE85443 dataset. Skin cancer development is related to the control of several DEGs through cyclin-dependent protein serine/threonine kinase activity, cell cycle regulation, and activation of the NIMA kinase pathways. The cytoHubba plugin in Cytoscape identified 12 hub genes from PPI; among these 3 DEGs, namely, AURKA, CDK4, and PLK1 were significantly associated with survival (P < 0.05) and highly expressed in skin cancer tissues. For validation purposes, ROC curve analysis indicated two biomarkers: AURKA (area under the curve (AUC) value = 0.8) and PLK1 (AUC value = 0.7), which were in an acceptable range. Further translational research, including clinical experiments, teratogenicity tests, and in-vitro or in-vivo studies, will be performed to evaluate the expression of these identified biomarkers regarding the prognosis of skin cancer patients.

The occurrences of skin cancers and malignant diseases jeopardize human health. To study the changes of subcutaneous structure of skin cancer tissue in vitro and monitor the dynamics of skin cancer development in skin structure, spectral domain optical coherence tomography (SD-OCT) was used to scan the skin tissue of basal cell carcinoma in vitro and to establish the model of dorsal skin fold window chamber (DSFC) melanoma in nude mouse. One dimensional scanning signal, two dimensional tomographic image and three dimensional structural image of the skin sample were obtained by tomographic scanning and imaging reconstruction of the subcutaneous structure of the lesion tissue. Comparative analysis showed no significant change presented in the external morphology of the skin of basal cell carcinoma. There was non-scattered signal area in the internal tissue. Two-dimensional tomographic images showed an elliptically black-nest lesion located in the subepidermal area of the skin with about 155.972 μm in length and 150.192 μm in width. Meanwhile, the DSFC melanoma with tomographic imaging model was consecutively observed for 11 days. It showed that tumor bulges appeared on the skin surface and subcutaneous capillaries became clear with the proliferation of melanoma cells. In the two dimensional OCT image, the penetrating depth of the laser beam decreased with the depth of tomography at different time after tumor implantation attenuates, but the OCT signal from the skin layer enhanced due to the strong scattering effect. It is probably caused by the generation of melanoma and its continuous invading upwards. The results show that the internal morphology of the skin tissue of basal cell carcinoma in vitro has changed, and black lesion region without any OCT signal appeared. The dynamic development of melanoma in nude mouse in vivo has an impact on skin tissue, varied morphological form in the skin layer at different time periods is revealed by OCT images. The study provides the promising support in image and data basis for the diagnosis and treatment of basal cell carcinoma. At the same time, dynamic monitoring of melanoma process is also of great significance for the study of skin cancer pathological process.

Highly Q-factor THz sensor for biosensing based on traveling wave propagation in the metamaterial cavity

TPS3161 Background: Fibroblast activation protein alpha (FAP) is a 170 kDa transmembrane glycoprotein expressed during development, active tissue remodeling, and cancer. Overexpression on cancer-associated fibroblasts in the tumor microenvironment, and on some cancer cells of mesenchymal origin, leads to the presence of FAP in &gt; 90% of epithelial tumors, making FAP a compelling anti-cancer target. PNT6555, a potent FAP-targeting compound with rapid clearance from normal tissues and prolonged tumor retention in preclinical models1, is a radioligand consisting of a DOTA chelator (1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetic acid) and a FAP-targeting moiety (Bz-D-Ala-boroPro) connected via an aminomethyl linker. The corresponding gallium-68 and lutetium-177 chelates constitute the imaging and therapeutic theranostic pair of PNT6555 under evaluation in this phase I study. Methods: FRONTIER (NCT05432193) is a multicenter, open-label, multi-dose phase I study of PNT6555 in participants with pancreatic ductal adenocarcinoma, esophageal cancer, colorectal cancer, melanoma skin cancer, cholangiocarcinoma, or soft tissue sarcoma solid tumors with FAP over-expression. The primary aim is to evaluate the safety and tolerability of [Lu-177]-PNT6555 in order to determine a recommended phase II dose (RP2D). Dosimetry, pharmacokinetics, and tumor and immune responses will also be assessed for [Lu-177]-PNT6555, as well as safety, tolerability, and diagnostic performance of [Ga-68]-PNT6555 PET/CT. Key eligibility criteria include being refractory to prior treatment with no alternative available therapeutic options, having adequate organ function, and being FAP-positive on [Ga-68]-PNT6555 PET/CT scan, defined as ≥50% of lesions with an SUVmax of ≥1.5x the liver SUVmean. [Ga-68]-PNT6555 will be dosed at 120 - 220 MBq (3.2 - 5.9 mCi), with PET/CT initiated 90 (±30) min later. FAP-positive participants will receive [Lu-177]-PNT6555 once every 6 weeks for up to 6 cycles. Starting at 4 GBq (108 mCi) ±10%, [Lu-177]-PNT6555 may be escalated by 4 GBq, with a maximum planned dose of 12 GBq. De-escalation by 2 GBq may also occur. Dose finding will be guided by the modified toxicity probability interval (mTPI-2) statistical design with a targeted toxicity rate of 30%. The planned total sample size is 30, with targets of 3-12 DLT evaluable patients per dose level. Cohort 1 has been completed without a DLT. Enrollment to cohort 2 began in January 2023. 1. Hallet R, et al. Pre-clinical characterization of the novel fibroblast activation protein (FAP) targeting ligand PNT6555 for the imaging and therapy of cancer. Presented at SNMMI Annual Meeting April 2022; Vancouver, BC, Canada. Clinical trial information: NCT05432193 .

ABSTRACT Although miR-199a-5p is linked to the development of numerous cancers, its regulatory role in skin cancer is unclear. In this work, the impact of miR-199a-5p produced by adipose-derived stem cells on malignant melanoma skin cancer was investigated.30 pair tumor tissues and adjacent tissues were obtained from skin cancer patients. Adipose-derived stem cell (ADSCs) were isolated from adipose tissues harvested from healthy subjects. The mRNA relative expression was evaluated via qRT-PCR. Cell proliferation ability was measured via CCK-8 assay. Apoptosis was evaluated via flow cytometry. The connection between miR-199a-5p and SOX4 was confirmed via luciferase reporter assay. Western blot was conducted to evaluate protein expression. MiR-199a-5p was higher expressed in ADSCs exosomes and was lower expressed in skin cancer tissues and cells. ADSCs-derived exosomes inhibited cell invasion of skin cancer. MiR-199a-5p inhibitor enhanced cell viability and invasion. In addition, miR-199a-5p inhibitor suppressed cell apoptosis. MiR-199a-5p NC transfected ADSCs inhibited cell viability and invasion while miR-199a-5p mimic transfected ADSCs further inhibited cell viability and invasion. In addition, miR-199a-5p NC transfected ADSCs enhanced cell apoptosis while miR-199a-5p mimic transfected ADSCs further enhanced cell apoptosis. Luciferase supported the targetscan prediction that miR-199a-5p might control SOX4 expression. SOX4 expression was noticeably lower in the miR-199a-5p mimic group.Exosomes from adipose-derived stem cells inhibited skin cancer progression via miR-199a-5p/SOX4.

Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is an important approach for the treatment of some skin diseases and cancers. A major defect of this approach is that it is difficult for 5-ALA to accumulate around lesions in deeper regions of tissue, resulting in poor conversion to the active fluorophore and photodynamic efficiencies. Because of their targeting and controlled release abilities, nanogel carriers could solve this problem. In this paper, nanogels were prepared by using micro-emulsion polymerization with various biodegradable polyester crosslinkers (L-lactide and ε-caprolactone). The swelling and degradation properties and entrapment efficiency, drug loading and drug release ability of the nanogels were investigated. Nanogels co-cultured with skin cancer cells (A2058) allowed the efficiency of the PDT in vitro to be demonstrated. The results showed that the swelling rate of hydrogels reduced with increasing crosslinker levels, which caused a slow-down in the release of 5-ALA, but lipase accelerated degradation of nanogels increased 5-ALA concentrations in tumor cells and leading to higher PDT efficiency. It was proved by in vivo experiment indicating that the development of skin cancer tissues were efficiently inhibited by the 5-ALA loaded nanogels.

Traditional oriental treatments have employed withaferin A (WA), a natural substance derived from Withania somnifera, to treat neurological diseases. A clinical trial has been started to test WA in treating melanoma in light of recent studies that suggest this molecule may have the capacity to treat cancer. Here, the chemo preventive potential of WA was examined in a mouse model of chemically induced skin carcinogenesis. Pathological analyses showed that WA greatly reduced the development of skin tumours. According to morphological analyses of the skin tissues, WA prevented cell division rather than causing apoptosis during the development of skin cancer. A skin cell transformation model and antibody Micro array analysis both showed that WA prevented acetyl-CoA carboxylase 1 (ACC1) from being up-regulated by carcinogens. Transformable skin cells' anchorage-independent proliferation and oncogene activation were increased by ACC1 overexpression, whereas they were reduced by ACC1 knockdown. Additional research revealed that WA prevented activator protein 1 from becoming activated, which prevented tumour promotor-induced ACC1 gene transcription. WA was similarly effective at reducing ACC1 expression in melanoma cells. The up-regulation of ACC1 in tumours compared to nearby normal tissues was lastly validated by research employing human skin cancer tissues. In conclusion, our findings imply that withaferin A may be useful in chemoprevention and that ACC1 may be an important target of WA. Wiley Periodicals, Inc. 2015